What Is Distal Pancreatectomy, and When Is the Spleen Preserved?

Which lesions bring this up?

Cystic lesions found in the body or tail of the pancreas (such as certain types of IPMN or mucinous cystic neoplasms), neuroendocrine tumors, or exocrine-origin masses can all lead to consideration of distal pancreatectomy. The type of lesion is assessed as much as possible with imaging (CT, MRI/MRCP) and, when needed, EUS, though a definitive tissue diagnosis is often only confirmed by pathology after surgery.

Why does spleen preservation come up?

The spleen plays a role in the immune system, and preserving it when possible is a preferred goal for maintaining defenses against certain infections. However, preserving the spleen isn't always technically possible or oncologically appropriate; the decision is therefore shaped by the nature of the lesion and the findings during surgery.

Factors that influence the spleen-preservation decision

• Whether the lesion is likely benign, low-risk, or high-risk/invasive
• How close the lesion is to the splenic vessels (splenic artery/vein) and its relationship to them
• Whether extensive lymph node dissection is needed for oncologic reasons
• Whether the operation is performed laparoscopically/robotically or as open surgery, and the surgical team's experience with the technique
• Anatomical findings encountered during surgery; sometimes the plan made before surgery can change based on what is found during the operation

What to watch for when the spleen is preserved

When the spleen is preserved, the integrity of the vessels supplying it is carefully assessed; if blood flow through these vessels is compromised, spleen function can be affected. For this reason, spleen preservation should be seen as a goal planned before surgery that may still change depending on the findings during the operation.

What changes if the spleen is removed?

In cases considered to involve invasive cancer, or where wider oncologic resection is needed, the spleen may be removed together with the pancreatic tissue. When the spleen is removed, the approach to protecting the patient against certain infections is planned individually by the team; this planning can include vaccination and, when needed, early medical evaluation, and is considered together with the patient's age and overall health.

Follow-up after surgery

After surgery, patients are closely monitored for pancreatic fistula, bleeding, and infection. The pathology result clarifies the exact type of the lesion and whether additional treatment is needed. The effect of the remaining pancreatic tissue on digestion and blood sugar regulation is also part of the follow-up process.